Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Rebecca Merica"'
Autor:
Lydia Navarrete-Galvan, Michael Guglielmo, Judith Cruz Amaya, Julie Smith-Gagen, Vincent C. Lombardi, Rebecca Merica, Dorothy Hudig
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-13 (2022)
Abstract Background The NK cell line NK-92 and its genetically modified variants are receiving attention as immunotherapies to treat a range of malignancies. However, since NK-92 cells are themselves tumors, they require irradiation prior to transfer
Externí odkaz:
https://doaj.org/article/08b208ea7b0644029d4d0450d419a938
Autor:
Lydia T Navarrete-Galvan, Michael Guglielmo, Judith Cruz Amaya, Julie Smith-Gagen, Vincent C. Lombardi, Rebecca Merica, Dorothy Hudig
Publikováno v:
Journal of translational medicine. 20(1)
BackgroundThe NK cell line NK-92 and its genetically modified variants are receiving attention as immunotherapies to treat a range of malignancies. However, since NK-92 cells are themselves tumors, they require irradiation prior to transfer and are p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd4c33aedd7c0974079a175288815dc0
https://pubmed.ncbi.nlm.nih.gov/35366943
https://pubmed.ncbi.nlm.nih.gov/35366943
Autor:
Lydia T Navarrete-Galvan, Michael Guglielmo, Judith Cruz Amaya, Rebecca Merica, Julie Smith-Gagen, Vincent C Lombardi, Dorothy Hudig
Publikováno v:
The Journal of Immunology. 208:62.03-62.03
Adoptively transferred NK-92 cells and genetically modified variants must undergo irradiation to prevent proliferation, since NK-92 cells are themselves tumors. This malignant quality also makes NK-92 cells susceptible to attack by patients’ NK cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e4d931a30f2c27d866db917e252a1ec
https://doi.org/10.4049/jimmunol.208.supp.62.03
https://doi.org/10.4049/jimmunol.208.supp.62.03
Autor:
Lydia T Navarrete-Galvan, Michael Guglielmo, Alexander Sung, Julie Smith-Gagen, Vincent Lombardi, Rebecca Merica, Dorothy Hudig
Publikováno v:
The Journal of Immunology. 206:57.09-57.09
The NK cell line NK-92 and transgenic variants are receiving attention as adoptive transfer immunotherapies to treat a range of malignancies. However, since NK-92s are themselves tumors, they require irradiation prior to transfer and are potentially
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc4fb85f57db9aa04daae47757b8f388
https://doi.org/10.4049/jimmunol.206.supp.57.09
https://doi.org/10.4049/jimmunol.206.supp.57.09
Autor:
Alexander P Sung, Lydia T Navarrete-Galvan, Michael Guglielmo, Julie Smith-Gagen, Douglas D Redelman, Rebecca Merica, Dorothy Hudig
Publikováno v:
The Journal of Immunology. 204:148.44-148.44
Serial killers are more desirable than single-hit attackers when it comes to treating cancer. Antibody-dependent cell-mediated cytotoxicity (ADCC) mediated by NK lymphocytes is a significant component of many monoclonal antibody anti-cancer immunothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62ae416b9487e09bb404d3857dc44cce
https://doi.org/10.4049/jimmunol.204.supp.148.44
https://doi.org/10.4049/jimmunol.204.supp.148.44
Autor:
Lydia T Navarrete-Galvan, Michael Guglielmo, Julie Smith-Gagen, Rebecca Merica, Vincent C Lombardi, Dorothy Hudig
Publikováno v:
The Journal of Immunology. 204:88.5-88.5
Serial killers are much more productive than one-hit wonders, especially when it comes to killing cancer. Natural killer lymphocytes are significant cells in many anti-cancer immunotherapies, such as monoclonal antibody based- and adoptive cell trans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30b76f7481db3c94dd7c84d1e276758b
https://doi.org/10.4049/jimmunol.204.supp.88.5
https://doi.org/10.4049/jimmunol.204.supp.88.5
Autor:
Dorothy Hudig, Keli Tokunaga, Alexander P Sung, Michael J Guglielmo, Julie Smith-Gagen, Rebecca Merica, Doug Redelman
Publikováno v:
The Journal of Immunology. 202:182.50-182.50
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is characterized by fatigue that does not improve with rest and worsens with exertion. ME/CFS may involve inflammation in the brain and/or be associated with viral infections. Increased numb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33058d878e07efe6508665cfb5969cc8
https://doi.org/10.4049/jimmunol.202.supp.182.50
https://doi.org/10.4049/jimmunol.202.supp.182.50
Publikováno v:
Experimental Neurology. 164:362-370
Allogeneic or xenogenic tissues exhibit prolonged survival when grafted into the brain parenchyma in comparison to grafting into peripheral sites. The brain, therefore, has long been considered an immunologically privileged site. However, the immunol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b37372f9d08404514e1a32fed95afcbb
https://doi.org/10.1006/exnr.2000.7435
https://doi.org/10.1006/exnr.2000.7435
Publikováno v:
Scopus-Elsevier
It is thought that protective immunity is mediated in part by Ag-experienced T cells that respond more quickly and vigorously than naive T cells. Using adoptive transfer of OVA-specific CD4 T cells from TCR transgenic mice as a model system, we show
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a95b68f11a47a2ca426f845579ef0086
https://doi.org/10.4049/jimmunol.164.9.4551
https://doi.org/10.4049/jimmunol.164.9.4551
Autor:
Randolph J. Noelle, Elizabeth Ingulli, Julia G. Johnson, Paul Garside, Rebecca Merica, Marc K. Jenkins
Publikováno v:
Science. 281:96-99
Early events in the humoral immune response were visualized in lymph nodes by simultaneous tracking of antigen-specific CD4 T and B cells after immunization. The T cells were initially activated in the T cell areas when the B cells were still randoml
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b4ea567d119022314408cb25da65172
https://doi.org/10.1126/science.281.5373.96
https://doi.org/10.1126/science.281.5373.96